About
Technology
Issues
FAQ
Links
Official Page
Darbepoetin alfa has a longer circulating half-life and greater in vivo potency than recombinant human erythropoietin
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.